Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response
  2. Sui, Yongjun; Lewis, George K.; Wang, Yichuan; Berckmueller, Kurt; Frey, Blake; Dzutsev, Amiran; Vargas-Inchaustegui, Diego; Mohanram, Venkatramanan; Musich, Thomas; Shen, Xiaoying; DeVico, Anthony; Fouts, Timothy; Venzon, David; Kirk, James; Waters, Robert C.; Talton, James; Klinman, Dennis; Clements, John; Tomaras, Georgia D.; Franchini, Genoveffa; Robert-Guroff, Marjorie; Trinchieri, Giorgio; Gallo, Robert C.; Berzofsky, Jay A.
  3. The Journal of clinical investigation. 2019, Mar 1; 129(3): 1314-1328.
  1. 2.   Gp96(SIV)Ig immunization induces potent polyepitope specific, multifunctional memory responses in rectal and vaginal mucosa
  2. Strbo, N.; Vaccari, M.; Pahwa, S.; Kolber, M. A.; Fisher, E.; Gonzalez, L.; Doster, M. N.; Hryniewicz, A.; Felber, B. K.; Pavlakis, G. N.; Franchini, G.; Podack, E. R.
  3. Vaccine. 2011, Mar; 29(14): 2619-2625.
  1. 3.   Adaptive control of innate immunity
  2. Shanker, A.
  3. Immunology Letters. 2010, Jul; 131(2): 107-112.
  1. 4.   Brugia malayi Excreted/Secreted Proteins at the Host/Parasite Interface: Stage- and Gender-Specific Proteomic Profiling
  2. Bennuru, S.; Semnani, R.; Meng, Z.; Ribeiro, J.; Veenstra, T. D.; Nutman, T. B.
  3. Plos Neglected Tropical Diseases. 2009 3(4):
  1. 6.   Effect of therapeutic immunization using Ad5/35 and MVA vectors on SIV infection of rhesus monkeys undergoing antiretroviral therapy
  2. Shimada, M.; Wang, H. B.; Kondo, A.; Xu, X. P.; Yoshida, A.; Shinoda, K.; Ura, T.; Mizuguchi, H.; Klinman, D.; Luo, J. L.; Bai, H.
  3. Gene Therapy. 2009 16(2): 218-228.
  1. 7.   Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution
  2. Das, A. T.; Klaver, B.; Centlivre, M.; Harwig, A.; Ooms, M.; Page, M.; Almond, N.; Yuan, F.; Piatak, M.; Lifson, J. D.; Berkhout, B.
  3. Retrovirology. 2008 5 AR 44
  1. 8.   Live vaccines for human metapneumovirus designed by reverse genetics
  2. Buchholz, U. J.; Nagashima, K.; Murphy, B. R.; Collins, P. L.
  3. Expert Review of Vaccines. 2006, Oct; 5(5): 695-706.
  1. 9.   Impact of vaccine-induced mucosal high-avidity CD8(+)CTLs in delay of AIDS viral dissemination from mucosa
  2. Belyakov, I. M.; Kuznetsov, V. A.; Kelsall, B.; Klinman, D.; Moniuszko, M.; Lemon, M.; Markham, P. D.; Pal, R.; Clements, J. D.; Lewis, M. G.; Strober, W.; Franchini, G. A.; Berzofsky, J. A.
  3. Blood. 2006, Apr; 107(8): 3258-3264.
  1. 10.   Human monoclonal antibodies to the S glycoprotein and related proteins as potential therapeutics for SARS
  2. Zhang, M. Y.; Choudhry, V.; Xiao, X. D.; Dimitrov, D. S.
  3. Current Opinion in Molecular Therapeutics. 2005, APR; 7(2): 151-156.
  1. 11.   Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis
  2. McMurray, D. N.; Allen, S. S.; Jeevan, A.; Lasco, T.; Cho, H.; Skwor, T.; Yamamoto, T.; McFarl, C.; Yoshimura, T.
  3. Tuberculosis. 2005, SEP-NOV; 85(5-6): 295-301.
  1. 12.   Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
  2. Biragyn, A.; Ruffini, P. A.; Coscia, M.; Harvey, L. K.; Neelapu, S. S.; Baskar, S.; Wang, J. M.; Kwak, L. W.
  3. Blood. 2004, OCT 1; 104(7): 1961-1969.
  1. 13.   Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles
  2. Mossman, S. P.; Pierce, C. C.; Watson, A. J.; Robertson, M. N.; Montefiori, D. C.; Kuller, L.; Richardson, B. A.; Bradshaw, J. D.; Munn, R. J.; Hu, S. L.; Greenberg, P. D.; Benveniste, R. E.; Haigwood, N. L.
  3. Aids Research and Human Retroviruses. 2004 20(4): 425-434.
  1. 14.   Next generation DNA vaccines for HIV-1
  2. Boyer, J. D.; Chattergoon, M.; Muthumani, K.; Kudchodkar, S.; Kim, J.; Bagarazzi, M.; Pavlakis, G.; Sekaly, R.; Weiner, D. B.
  3. Journal of Liposome Research. 2002 12(1-2): 137-142.
  1. 15.   Issues for improving multiplasmid DNA vaccines for HIV-1
  2. Muthumani, K.; Kudchodkar, S.; Zhang, D. H.; Bagarazzi, M. L.; Kim, J. J.; Boyer, J. D.; Ayyavoo, V.; Pavlakis, G. N.; Weiner, D. B.
  3. Vaccine. 2002 20(15, Special Issue): 1999-2003.
  1. 17.   DNA immunization of mice and macaques with plasmids encoding hepatitis C virus envelope E2 protein expressed intracellularly and on the cell surface
  2. Forns, X.; Emerson, S. U.; Tobin, G. J.; Mushahwar, I. K.; Purcell, R. H.; Bukh, J.
  3. Vaccine. 1999 17(15-16): 1992-2002.
  1. 18.   Developmental Differences Determine Larval Susceptibility to Nitric Oxide-Mediated Killing in a Murine Model of Vaccination Against Schistosoma Mansoni
  2. Ahmed, S. F.; Oswald, I. P.; Caspar, P.; Hieny, S.; Keefer, L.; Sher, A.; James, S. L.
  3. Infection and Immunity. 1997 65(1): 219-226.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel